Tevogen Bio to Become Publicly Listed on NYSE via Business

Tevogen Bio Inc. (“Tevogen Bio”) is an advanced-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell...

Related Keywords

Cayman Islands ,Cayman ,00 ,Delaware ,United States ,New York ,Jeffrey Feike ,Susan Podlogar ,Curtis Patton ,Ryan Saadi ,Tevogen Bio ,Suren Ajjarapu ,Victor Sordillo ,Semper Paratu ,Lindee Goh ,Leadership Team ,Semper Paratus Acquisition Corporation ,Cohen Company Capital ,Tevogen Bio Inc ,Hogan Lovells ,Board Of Directors Tevogen Holdings ,Tevogen Bio Holdings Inc ,J Vb Financial Group ,Tevogen Communications ,Exchange Commission ,Tevogen Holdings ,Nasdaq ,Nelson Mullins Riley Scarborough ,Cayman Island ,Bio Inc ,Tevogen Bio Holdings ,Cytotoxict Lymphocytes ,Killert Cells ,Semper Paratus ,Professor Curtis Patton ,Current Report ,Company Capital Markets ,Financial Group ,Nelson Mullins Riley ,Merger Agreement ,Securities Act ,Paratus Acquisition ,Nasdaq Lgst ,Business Combination ,Clinical Stage ,Ffectinga Merger ,Asset Acquisition ,Multiple Sectors ,Reorganization ,